About this document
Vitamin D in First Episode Psychosis Trial by Francisco Jose Ramirez Perdomo is a document available to read on EtoBox.
The DFEND study is a randomized, double-blind, placebo-controlled trial aimed at evaluating the effects of high-dose vitamin D supplementation on mental health outcomes in individuals experiencing their first episode of psychosis. Participants will receive either 120,000 IU/month of vitamin D or a placebo for six months, with the primary outcome being the total Positive and Negative Syndrome Scale (PANSS) score at follow-up. This study seeks to address the clinical uncertainty regarding the benefits of rout
- Author
- Francisco Jose Ramirez Perdomo
- Language
- EN